HUMAN PERFORMANCE ANGLE
TAMPA, FL / ACCESS Newswire / November 3, 2025 / When endurance athlete John Borden launches into his 100-mile Tampa 100 run this November, he won't just be racing for a finish time - he will be running toward an entirely new identity.
Borden, who struggled for years with burnout, chronic stress, and emotional collapse post-career, credits plant medicine, psilocybin-assisted integration, somatic training, and therapeutic lifestyle design for rebuilding his body, nervous system, and purpose. His 100-mile ultra effort is not just a physical test - it is an embodied ceremony of rebirth.
His run will culminate live on stage at the Cannadelic Global Summit where he will share the journey that carried him from breakdown to breakthrough.
The Athlete + The Ceremony
Borden represents a growing category of modern athletes who are using psychedelics not for escapism - but for regulation, recovery, neural rewiring, and resilience building.
He is not sponsored by a shoe brand. He is sponsored by healing.
His keynote-style final 20-minute stage share will unpack:
Why athletes are uniquely vulnerable to identity collapse after career shift
How psilocybin + intentional integration can accelerate emotional repair
Building flow-state through nervous system literacy
Using endurance as medicine - not punishment
How plant medicine helped him restore his love for movement itself
About Cannadelic Global 2025
Presented by the Neurodivergent Empowerment Institute (NEI), Cannadelic Global merges plant medicine, psychedelic research, inclusive mental health, and human potential into one singular transformational summit.
This year's theme centers on connection, identity reinvention, and the intelligence of the body.
Event Details:
Cannadelic Global Summit 2025
November 9, 2025
2201 1st Ave S, St. Petersburg, FL 33712
Tickets: https://cannadelic.miami/get-tickets/
Media Contact: ethan@bionicbloom.org
Contact:
Ethan Owens
ethan@bionicbloom.org
Tampa Bay, FL
https://cannadelic.miami/get-tickets/
SOURCE: Bionic Bloom
View the original press release on ACCESS Newswire